New interferon approved for chronic hepatitis C.
D000998:Antiviral Agents / Q000627:therapeutic use*; D017277:Drug Approval; D016174:Hepacivirus; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D007370:Interferon Type I; D016898:Interferon-alpha; D011994:Recombinant Proteins; C050739:interferon alfacon-1